Cargando…
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for Alzheimer’s disease (AD), have yielded significant insights into the pathogenic mechanism. Among the three common coding variants, APOE*ε4 increases, whereas APOE*ε2 decreases the risk of late-onset AD compared with...
Autores principales: | Li, Zonghua, Shue, Francis, Zhao, Na, Shinohara, Mitsuru, Bu, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640652/ https://www.ncbi.nlm.nih.gov/pubmed/33148290 http://dx.doi.org/10.1186/s13024-020-00413-4 |
Ejemplares similares
-
APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020) -
APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022) -
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022) -
Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013) -
Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease
por: Inoue, Yasuteru, et al.
Publicado: (2023)